$11.17
-0.12-1.06%
最終更新: Oct 2, 4:39 PM
$11.17
-0.12-1.06%
Benzinga
Benzinga
Benzinga
金曜日, 10 02
Benzinga
© 2026 Benzinga | All Rights Reserved
Vir Biotechnology (VIR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.88 | $0.38 | $-0.47 | $-0.80 |
| Actual | $0.47 | $-0.85 | $-0.31 | $-1.17 |
| Surprise | -46.6% | -323.7% | +34.0% | -46.3% |
| Revenue | ||||
| Estimate | $229.7M | $122.5M | $19.4M | $4.0M |
| Actual | $238.9M | $-29000 | $64.1M | $240000 |
| Surprise | +4.01% | -100.0% | +230.1% | -94.0% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.75 | $-0.66 | $-0.66 | $-0.68 |
| Revenue | ||||
| Consensus | $905832 | $6.7M | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $0.47 | $0.88 | -46.6 % |
| Q1 | May 6, 2026 | $-0.85 | $0.38 | -323.7 % |
| Q4 | Feb 23, 2026 | $-0.31 | $-0.47 | 34.0 % |
| Q3 | Nov 5, 2025 | $-1.17 | $-0.80 | -46.3 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $238.95M | $229.72M | 4.01 % |
| Q1 | May 6, 2026 | $-29.00K | $122.54M | -100.0 % |
| Q4 | Feb 23, 2026 | $64.07M | $19.41M | 230.1 % |
| Q3 | Nov 5, 2025 | $240.00K | $4.01M | -94.0 % |